CryoLife Financial Statements From 2010 to 2024
| CYL Stock | EUR 27.20 0.20 0.74% |
Check CryoLife financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CryoLife's main balance sheet or income statement drivers, such as , as well as many indicators such as . CryoLife financial statements analysis is a perfect complement when working with CryoLife Valuation or Volatility modules.
CryoLife |
CryoLife Company Operating Margin Analysis
CryoLife's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current CryoLife Operating Margin | 0.05 % |
Most of CryoLife's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CryoLife is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, CryoLife has an Operating Margin of 0.0484%. This is 100.14% lower than that of the Healthcare sector and 100.12% lower than that of the Medical Devices industry. The operating margin for all Germany stocks is 100.88% lower than that of the firm.
CryoLife Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining CryoLife's current stock value. Our valuation model uses many indicators to compare CryoLife value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across CryoLife competition to find correlations between indicators driving CryoLife's intrinsic value. More Info.CryoLife is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the CryoLife's earnings, one of the primary drivers of an investment's value.About CryoLife Financial Statements
CryoLife stakeholders use historical fundamental indicators, such as CryoLife's revenue or net income, to determine how well the company is positioned to perform in the future. Although CryoLife investors may analyze each financial statement separately, they are all interrelated. For example, changes in CryoLife's assets and liabilities are reflected in the revenues and expenses on CryoLife's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in CryoLife. Please read more on our technical analysis and fundamental analysis pages.
CryoLife, Inc., together with its subsidiaries, manufactures, processes, and distributes medical devices and implantable human tissues for use in cardiac and vascular surgeries worldwide. CryoLife, Inc. was founded in 1984 and is headquartered in Kennesaw, Georgia. CRYOLIFE INC operates under Medical Devices classification in Germany and is traded on Frankfurt Stock Exchange. It employs 1100 people.
Currently Active Assets on Macroaxis
Other Information on Investing in CryoLife Stock
CryoLife financial ratios help investors to determine whether CryoLife Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CryoLife with respect to the benefits of owning CryoLife security.